开拓药业-B拟折让约15.03%发行3048.75万股认购股份 净筹约4978万港元

Core Viewpoint - The company plans to issue 30.4875 million subscription shares at a price of HKD 1.64 per share, representing a discount of approximately 15.03% from the last trading price of HKD 1.93 [1] Group 1: Subscription Details - The subscription is aimed at raising approximately HKD 49.78 million, which will be used for general working capital and the Phase III clinical trial of KX-826 [1]